C18:0-d7 GD1b Ceramide (d18:1/18:0-d7)

C18:0-d7 GD1b Ceramide (d18:1/18:0-d7)

• UNSPSC Description: C18:0-d7 GD1b Ceramide (d18:1/18:0-d7) is deuterium labeled C18:0 GD1b Ceramide (d18:1/18:0)[1].
• Target Antigen: Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Others
• Field of Research: Others
• Smiles: OC[C@@H](O)[C@@H](O)[C@H]1[C@@H](NC(C)=O)[C@@H](O)C[C@@](C(O)=O)(O[C@@H]([C@H]([C@H]2C(NC(C)=O)[C@@H](O)C[C@@](C(O)=O)(O[C@H]3[C@@H](O)[C@H](O[C@H]4[C@@H](O)[C@H]([C@H](OC[C@H](NC(CCCCCCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O)C(O)/C=C/CCCCCCCCCCCCC)O[C@@H]4CO)O)O[C@H](CO)[C@@H]3O[C@@H]5O[C@H](CO)[C@H](O)[C@H](OC6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H]5NC(C)=O)O2)O)CO)O1
• Molecular Weight: 1845.12
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported